Collaborative Clinical Trials in Drug Abuse (R01)

The summary for the Collaborative Clinical Trials in Drug Abuse (R01) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Collaborative Clinical Trials in Drug Abuse (R01): -This Funding Opportunity Announcement (FOA) issued by the National Institute on Drug Abuse, National Institutes of Health, is a reissuance of PAR-04-073, Collaborative Clinical Trials in Drug Abuse, published in the NIH Guide for Contracts and Grants, March 9, 2004 at http://grants.nih.gov/grants/guide/pa-files/PAR-04-073.html. This announcement provides guidelines for the development, review, and funding of Collaborative Clinical Trials in Drug Abuse (CCTDA) through the solicitation of Research Project Grant (R01) applications from institutions/organizations that propose to carry out clinical trials using a common protocol at collaborating sites. One of the sites should be the coordinating site for the trial. Each site must submit a separate R01 application. Although a foreign institution may be a participating site, the coordinating site must be a domestic institution. -Purpose. The National Institute on Drug Abuse (NIDA) seeks to increase the collaboration of investigators at different sites in order to address critical issues in the treatment of substance-related disorders that require sample sizes greater than a single site can reasonably attain. The expectation for the collaborative effort is that there will be implementation of common clinical trials across different sites in order to study patient outcomes, patient factors, provider factors, setting characteristics, interactions of these, or other effects where pooled samples are appropriate and necessary for the hypotheses under consideration. -Mechanism of Support. This FOA will utilize the NIH Research Project Grant (R01) award mechanism.
Federal Grant Title: Collaborative Clinical Trials in Drug Abuse (R01)
Federal Agency Name: National Institutes of Health
Grant Categories: Education Health
Type of Opportunity: Discretionary
Funding Opportunity Number: PAR-07-232
Type of Funding: Grant
CFDA Numbers: 93.279
CFDA Descriptions: Drug Abuse and Addiction Research Programs
Current Application Deadline: Multiple Receipt Dates - See Link to Full Announce
Original Application Deadline: Multiple Receipt Dates - See Link to Full Announce
Posted Date: Feb 23, 2007
Creation Date: Dec 05, 2008
Archive Date: Feb 02, 2010
Total Program Funding:
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: No
Applicants Eligible for this Grant
State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility
Foreign institutions are eligible to apply. Eligible agencies of the Federal Government can apply. Faith-based or community-based organizations can apply.
Link to Full Grant Announcement
Information not provided
Grant Announcement Contact
NIH OER [email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [[email protected]]
Similar Government Grants
• Pilot and Feasibility Studies in Preparation for Substance Use and HIV Prevention Interven...
• Neural Ensembles & Used Substances (NExUS) Collaboratory: Building a Multimodal Inventory ...
• Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Clinical Tr...
• Limited Competition: Growing Great Ideas: Research Education Course in Entrepreneurship an...
• Science Track Award for Research Transition (START) Program (R03, Clinical Trial Optional)
• NIDA Phase II Small Business Innovation Research (SBIR [R44]) Competing Renewal Awards
• Drug Abuse Aspects of Hiv/Aids and Other Infections
• Epidemiology of Drug Abuse
More Grants from the National Institutes of Health
• HIV/AIDS Clinical Trials Network Statistical and Data Management Centers (UM1 Clinical Tri...
• HIV/AIDS Clinical Trials Network Laboratory Centers (UM1 Clinical Trial Required)
• HIV/AIDS Clinical Trials Network Clinical Trials Units (UM1 Clinical Trial Required)
• HIV/AIDS Clinical Trials Network Leadership and Operations Centers (UM1 Clinical Trial Req...
• Advancing Real-World Effectiveness Evidence for Rapid-Acting Psychotropic Interventional D...

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2026 FederalGrants.com